Expression and diagnostic values of calretinin and CK5/6 in cholangiocarcinoma

被引:0
|
作者
Zhang L. [1 ,2 ,3 ]
Frank R. [1 ]
Furth E.E. [1 ]
Ziober A.F. [1 ]
LiVolsi V.A. [1 ]
Zhang P.J. [1 ,4 ]
机构
[1] Department of Pathology and Laboratory Medicine, University of Pennsylvania Pearlman School of Medicine, Philadelphia, PA
[2] Departments of Pathology, University Medical Center of Princeton at Plainsboro, Rutgers Robert Wood Johnson Medical School, Plainsboro, NJ
[3] Department of Chemical Biology, Ernest Mario School of Pharmacy, Department of Pathology and Lab Medicine, Robert Wood Johnson Medical School, and Cancer Institute of New Jersey, Piscataway, NJ
[4] Department of Pathology, Philadelphia, PA 19104, 6 Founders
关键词
Calretinin; Cholangiocarcinoma; CK5/6 and immunohistochemistry; Differentiation;
D O I
10.1186/2162-3619-3-12
中图分类号
学科分类号
摘要
Background: Mesothelin, a mesothelial marker, has been found expressed in and as a potential treatment target of cholangioacarcinoma (CC). It is possible that CC may be derived from the cells sharing mesothelial markers. However, the expression of other mesothelial markers in CC is largely unknown.Methods: Thirty CC cases (10 extrahepatic and 20 intrahepatic) were retrieved from our institutional archive. The immunohistochemical study of Calretinin (DC8), WT1 (6F-H2), Lymphatic Endothelial Marker (D2-40), CK5/6 (D5/16 B4) and CK19 (b170) was done on formalin fixed paraffin embedded sections for 2-3 blocks of each case. We compared the expression levels between CC and normal bile duct (NBD) on the same block.Results: All of the CC and NBD are positive for CK19 (23/23) and negative for WT1 (0/23) and D2-40 (0/23), except one CC positive for D2-40(1/30, 3.3%) and one NBD positive for WT1 (1/23, 4.3%). Calretinin immunoreactivity was detected in 52.2% (12/23) of CC, but none in NBD (0/23). CK5/6 was also detectable in 73.3% (22/30) of CC and all NBD (30/30). Increased expression of calretinin and reduced expression of CK5/6 were more likely associated with CC than NBD (P < 0.001 and P = 0.002, respectively). The sequential staining pattern of positive calretinin and negative CK5/6 in calretinin negative cases has a sensitivity of 69.57% and a specificity of 100% for differentiating CC from NBD. CK5/6 expression was also more likely associated with well-differentiated CC (7/7 versus 12/20 in moderately differentiated, and 9/10 in poorly differentiated, P = 0.019) and extrahepatic CC (10/10 versus 12/20 in intrahepatic, P = 0.029), but there was no association between the calretinin expression and the CC grade or location.Conclusion: Calretinin and CK5/6 immunohistochemical stains may be useful for diagnosing a CC. Their immunohistochemical results should be interpreted with caution in the cases with differential diagnoses of mesothelioma and CC. A full mesothelioma panel, including WT1 and/or D2-40, is recommended to better define a mesothelial lineage. The biology of calretinin and CK5/6 expression in CC is unclear, but might shed light on identifying therapeutic targets for CC. © 2014 Zhang et al.; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 50 条
  • [41] Basal differentiation with CK5/6 in invasive ductal carcinomas of breast and prognostic factors
    Akcay, Eda Yilmaz
    Pak, Isin
    VIRCHOWS ARCHIV, 2007, 451 (02) : 147 - 148
  • [42] ERG Immunohistochemistry Combined with CK5/6 and AMACR in Prostate Needle Biopsy Evaluation
    Lee, S. L.
    Wang, C.
    Raya, S.
    Shuhong, L.
    Trpkov, K.
    Bismar, T. A.
    MODERN PATHOLOGY, 2013, 26 : 229A - 229A
  • [43] Cytokeratin (CK5, CK8, CK14) expression and presence of progenitor stem cells in human fetal thymuses
    Gupta, Richa
    Gupta, Tulika
    Kaur, Harjeet
    Sehgal, Shobha
    Aggarwal, Anjali
    Kapoor, Kanchan
    Sharma, Anshu
    Sahni, Daisy
    Singla, Suhalika
    CLINICAL ANATOMY, 2016, 29 (06) : 711 - 717
  • [44] Invasive Lobular Carcinomas Do Not Express Basal Cytokeratin Markers CK5/6, CK14 and CK17
    Khilko, Natalya
    Wang, Jianmin
    Wei, Bing
    Hicks, David G.
    Tang, Ping
    BREAST CANCER-BASIC AND CLINICAL RESEARCH, 2010, 4 : 49 - 55
  • [45] Invasive Lobular Carcinomas Do Not Express Basal Cytokeratin Markers CK5/6, CK14 and CK17
    Hilko, N. K.
    Wang, J.
    Hicks, D. G.
    Tang, P.
    MODERN PATHOLOGY, 2009, 22 : 50A - 50A
  • [46] Invasive Lobular Carcinomas Do Not Express Basal Cytokeratin Markers CK5/6, CK14 and CK17
    Khilko, N.
    Wang, J.
    Hicks, D. G.
    Tang, P.
    LABORATORY INVESTIGATION, 2009, 89 : 50A - 50A
  • [47] ERG Immunohistochemistry Combined with CK5/6 and AMACR in Prostate Needle Biopsy Evaluation
    Lee, S. L.
    Wang, C.
    Raya, S.
    Shuhong, L.
    Trpkov, K.
    Bismar, T. A.
    LABORATORY INVESTIGATION, 2013, 93 : 229A - 229A
  • [48] Impact of immunohistochemical markers, CK5/6 and E-cadherin on diagnostic agreement in non-invasive proliferative breast lesions
    MacGrogan, G.
    Arnould, L.
    de Mascarel, I.
    Vincent-Salomon, A.
    Penault-Llorca, F.
    Lacroix-Triki, M.
    Bibeau, F.
    Baranzelli, M. C.
    Fridman, V.
    Antoine, M.
    Becette, V.
    Brouste, V.
    Jacquemier, J.
    Mathoulin-Pelissier, S.
    HISTOPATHOLOGY, 2008, 52 (06) : 689 - 697
  • [49] Molecular classification of 225 breast invasive carcinomas by immunohistochemistry - a tissue microarray study comparing CK5, CK5/6, CK10, CK14, CK17, p63 and EGFR to define basal carcinoma subtype
    Pires, A. R. C.
    Fonseca, E. C.
    Kanedo, N. H. S.
    Gagliononi, N. C.
    de Souza, S. R.
    HISTOPATHOLOGY, 2010, 57 : 38 - 39
  • [50] Triple-negative breast cancer is associated with EGFR, CK5/6 and c-KIT expression in Malaysian women
    Pillai, Shant Kishen Kanapathy
    Tay, Annie
    Nair, Suseela
    Leong, Chee-Onn
    BMC CLINICAL PATHOLOGY, 2012, 12